Ballantyne Therapeutics Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Conv. Debt
  • Latest Deal Amount
  • $565K
Latest Deal Amount

Ballantyne Therapeutics General Information


The company is currently operating under stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Business Products and Services
Primary Office
  • 7805 Pemswood Street
  • Charlotte, NC 28277
  • United States
+1 (704) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ballantyne Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Convertible Debt 16-Oct-2015 $565K 00000 Completed Startup
To view Ballantyne Therapeutics’s complete valuation and funding history, request access »

Ballantyne Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Michael Roberts Ph.D Chief Executive Officer & President
You’re viewing 1 of 2 executive team members. Get the full list »

Ballantyne Therapeutics Board Members (1)

Name Representing Role Since
Simon Pedder Ph.D Self Board Member 000 0000
To view Ballantyne Therapeutics’s complete board members history, request access »